Pura Vida Investments’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Pura Vida Investments’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-80,500	Closed	-$353K	–	91
2015 Q1	$353K	Hold	80,500	–	–	0.18%	59
2014 Q4	$388K	Buy	+80,500	New	+$360K	0.14%	67

Other funds holding TLOG

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCA

Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's TLOG Position: Q2 2015 in Review

Pura Vida Investments sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q2 2015, closing a stake of 80,500 shares — an estimated $353K sold.

Pura Vida Investments first reported a position in TLOG in Q4 2014 and held it in 2 quarters. The position peaked at $388K in Q4 2014. 33 funds tracked by Wall St. Rank hold TLOG as of Q2 2015.

Pura Vida Investments reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q2 2015 after selling out during the quarter.
Pura Vida Investments sold 80,500 TetraLogic Pharmaceuticals Corporation shares in Q2 2015, an estimated $353K.
Pura Vida Investments first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2014 and held it in 2 quarters.
Pura Vida Investments's TetraLogic Pharmaceuticals Corporation position peaked at $388K in Q4 2014.
33 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q2 2015.

Based on Pura Vida Investments's 13F filing for Q2 2015, filed 14 Aug 2015.